Haukur Gunnarsson

High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer

M. Ringnér, P. Malmström, Å. Borg, 2010, Breast Cancer Research.

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

M. Ringnér, Å. Borg, N. Loman, 2010, Breast Cancer Research.

The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients

B. Agnarsson, R. Barkardottir, I. Reynisdottir, 2012, BMC Cancer.

Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.

Johan Staaf, Mårten Fernö, Markus Ringnér, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer

M. Ringnér, Å. Borg, O. Johannsson, 2013, Cancer medicine.

Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours

M. Ringnér, Å. Borg, R. Barkardottir, 2012, Breast Cancer Research and Treatment.

Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families

E. Gillanders, P. Møller, Å. Borg, 2010, Breast Cancer Research.

Mapping of genomic aberrations in non-BRCA1/2 familial breast cancer using array-CGH

Haukur Gunnarsson, 2009 .

Evidence against PALB2 involvement in Icelandic breast cancer susceptibility

E. Gillanders, B. Agnarsson, R. Barkardottir, 2008, Journal of Negative Results in Biomedicine.

The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714predict adverse outcome for breast cancer patients

B. Agnarsson, R. Barkardottir, I. Reynisdottir, 2012, BMC Cancer.